{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:01:12Z","timestamp":1793721672593,"version":"4.6.1"},"reference-count":73,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1097\/ico.0b013e318226bf97","type":"journal-article","created":{"date-parts":[[2011,12,7]],"date-time":"2011-12-07T04:58:10Z","timestamp":1323233890000},"page":"299-310","source":"Crossref","is-referenced-by-count":143,"title":["Diagnosis and Treatment of Ocular Chronic Graft-Versus-Host Disease: Report From the German\u2013Austrian\u2013Swiss Consensus Conference on Clinical Practice in Chronic GVHD"],"prefix":"10.1097","volume":"31","author":[{"given":"Tina","family":"Dietrich-Ntoukas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Cursiefen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrike","family":"Westekemper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Eberwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Reinhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Bertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Nepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Lawitschka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnd","family":"Heiligenhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berthold","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth M","family":"Messmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Meyer-ter-Vehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadezda","family":"Basara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildegard","family":"Greinix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel B","family":"Datiles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie J","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Z","family":"Pavletic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210204","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"R3-16-20210204","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/00003226-200310001-00004","article-title":"Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation.","volume":"22","author":"Ogawa","year":"2003","journal-title":"Cornea"},{"key":"R4-16-20210204","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/01.icu.0000233952.09595.d8","article-title":"Update on ocular graft versus host disease.","volume":"17","author":"Kim","year":"2006","journal-title":"Curr Opin Ophthalmol"},{"key":"R5-16-20210204","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.beha.2008.02.008","article-title":"Diagnosis and manifestations of chronic graft-versus-host disease.","volume":"21","author":"Filipovich","year":"2008","journal-title":"Best Pract Res Clin Haematol"},{"key":"R6-16-20210204","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.2353\/ajpath.2009.090318","article-title":"Epithelial mesenchymal transition in human ocular chronic graft-versus-host disease.","volume":"175","author":"Ogawa","year":"2009","journal-title":"Am J Pathol"},{"key":"R7-16-20210204","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/bmt.2009.346","article-title":"Differential chemokine expression in chronic GVHD of the conjunctiva.","volume":"45","author":"Westekemper","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"R8-16-20210204","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ajo.2003.10.036","article-title":"Antiinflammatory therapy for dry eye.","volume":"137","author":"Pflugfelder","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R10-16-20210204","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00347-005-1300-9","article-title":"Current treatment for dry eye syndrome [in German].","volume":"103","author":"Cursiefen","year":"2006","journal-title":"Ophthalmologe"},{"key":"R11-16-20210204","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","article-title":"Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group.","volume":"107","author":"Sall","year":"2000","journal-title":"Ophthalmology"},{"key":"R12-16-20210204","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.bmt.1705900","article-title":"Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.","volume":"41","author":"Wang","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"R13-16-20210204","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/01.ico.0000208813.17367.0c","article-title":"Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease.","volume":"25","author":"Rao","year":"2006","journal-title":"Cornea"},{"key":"R14-16-20210204","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/01.ico.0000208818.47861.1d","article-title":"Ophthalmic cyclosporine use in ocular GVHD.","volume":"25","author":"Lelli","year":"2006","journal-title":"Cornea"},{"key":"R15-16-20210204","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.survophthal.2009.02.002","article-title":"Topical ophthalmic cyclosporine: pharmacology and clinical uses.","volume":"54","author":"Donnenfeld","year":"2009","journal-title":"Surv Ophthalmol"},{"key":"R16-16-20210204","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/ICO.0b013e3181a16472","article-title":"High-frequency topical cyclosporine 0.05% in the treatment of severe dry eye refractory to twice-daily regimen.","volume":"28","author":"Dastjerdi","year":"2009","journal-title":"Cornea"},{"key":"R17-16-20210204","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1167\/iovs.04-1076","article-title":"Preclinical evaluation of a novel episcleral cyclosporine implant for ocular graft-versus-host disease.","volume":"46","author":"Kim","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R18-16-20210204","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bbmt.2006.02.003","article-title":"Ancillary therapy and supportive care of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report.","volume":"12","author":"Couriel","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"R19-16-20210204","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1600-0420.2007.01120.x","article-title":"Dry-eye syndrome after allogeneic stem-cell transplantation in children.","volume":"86","author":"Fahnehjelm","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"R20-16-20210204","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0161-6420(99)90023-4","article-title":"Ocular complications of pediatric bone marrow transplantation.","volume":"106","author":"Ng","year":"1999","journal-title":"Ophthalmology"},{"key":"R21-16-20210204","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/01.moh.0000245689.47333.ff","article-title":"Chronic graft versus host disease.","volume":"13","author":"Baird","year":"2006","journal-title":"Curr Opin Hematol"},{"key":"R22-16-20210204","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/bmt.2009.312","article-title":"Baseline profiles of ocular surface and tear dynamics after allogeneic hematopoietic stem cell transplantation in patients with or without chronic GVHD-related dry eye.","volume":"45","author":"Wang","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"R23-16-20210204","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.ophtha.2009.04.054","article-title":"Ocular findings after allogeneic hematopoietic stem cell transplantation.","volume":"116","author":"Tabbara","year":"2009","journal-title":"Ophthalmology"},{"key":"R24-16-20210204","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbmt.2005.10.023","article-title":"Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.","volume":"12","author":"Shulman","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"R25-16-20210204","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00417-006-0448-6","article-title":"Histological and immunohistochemical characterisation of conjunctival graft vs host disease following haematopoietic stem cell transplantation.","volume":"245","author":"Auw-Haedrich","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R26-16-20210204","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1001\/archopht.1989.01070020413046","article-title":"The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease.","volume":"107","author":"Jabs","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"R27-16-20210204","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/sj.bmt.1704453","article-title":"Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease.","volume":"33","author":"Robinson","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"R28-16-20210204","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.beha.2008.02.014","article-title":"Ancillary and supportive care in chronic graft-versus-host disease.","volume":"21","author":"Couriel","year":"2008","journal-title":"Best Pract Res Clin Haematol"},{"key":"R29-16-20210204","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.bbmt.2010.06.015","article-title":"Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD.","volume":"16","author":"Wolff","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"R30-16-20210204","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00003226-200105000-00020","article-title":"Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK506 and corticosteroids.","volume":"20","author":"Ogawa","year":"2001","journal-title":"Cornea"},{"key":"R31-16-20210204","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/bjo.2005.082792","article-title":"Corneal calcification following intensified treatment with sodium hyaluronate artificial tears.","volume":"90","author":"Bernauer","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"R32-16-20210204","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0929-6646(09)60125-X","article-title":"Recurrent corneal perforation and acute calcareous corneal degeneration in chronic graft-versus-host disease.","volume":"105","author":"Yeh","year":"2006","journal-title":"J Formos Med Assoc"},{"key":"R33-16-20210204","first-page":"635","article-title":"Treatment of chronic blepharokeratoconjunctivitis with local calcineurin inhibitors [in German].","volume":"106","author":"Auw-Hadrich","year":"2009","journal-title":"Ophthalmologe"},{"key":"R34-16-20210204","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2310\/7750.2008.07026","article-title":"Use of pimecrolimus cream in disorders other than atopic dermatitis.","volume":"12","author":"Day","year":"2008","journal-title":"J Cutan Med Surg"},{"key":"R35-16-20210204","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/sj.eye.6702367","article-title":"Tacrolimus ointment vs steroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis.","volume":"21","author":"Nivenius","year":"2007","journal-title":"Eye (Lond)"},{"key":"R36-16-20210204","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/01.ico.0000176611.88579.0a","article-title":"Efficacy of commercially available topical cyclosporine A 0.05% in the treatment of meibomian gland dysfunction.","volume":"25","author":"Perry","year":"2006","journal-title":"Cornea"},{"key":"R37-16-20210204","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/jop.2006.22.47","article-title":"Efficacy of topical cyclosporin 0.05% in the treatment of posterior blepharitis.","volume":"22","author":"Rubin","year":"2006","journal-title":"J Ocul Pharmacol Ther"},{"key":"R38-16-20210204","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0002-9394(14)71750-7","article-title":"Efficacy of doxycycline and tetracycline in ocular rosacea.","volume":"116","author":"Frucht-Pery","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"R39-16-20210204","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00003226-200303000-00002","article-title":"Systemic linoleic and gamma-linolenic acid therapy in dry eye syndrome with an inflammatory component.","volume":"22","author":"Barabino","year":"2003","journal-title":"Cornea"},{"key":"R40-16-20210204","first-page":"649","article-title":"Oral flaxseed oil (Linum usitatissimum) in the treatment for dry-eye Sjogrens syndrome patients [in Portuguese].","volume":"70","author":"Pinheiro","year":"2007","journal-title":"Arq Bras Oftalmol"},{"key":"R41-16-20210204","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/bjo.79.11.1007","article-title":"Sodium hyaluronate eyedrops in the treatment of dry eyes.","volume":"79","author":"Shimmura","year":"1995","journal-title":"Br J Ophthalmol"},{"key":"R42-16-20210204","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1055\/s-2006-927266","article-title":"Comparative study of treatment of the dry eye syndrome due to disturbances of the tear film lipid layer with lipid-containing tear substitutes [in German].","volume":"223","author":"Dausch","year":"2006","journal-title":"Klin Monbl Augenheilkd"},{"key":"R43-16-20210204","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/01.rhu.0000135553.08057.21","article-title":"Successful treatment of dry mouth and dry eye symptoms in Sjogrens syndrome patients with oral pilocarpine: a randomized, placebo-controlled, dose-adjustment study.","volume":"10","author":"Papas","year":"2004","journal-title":"J Clin Rheumatol"},{"key":"R44-16-20210204","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ajo.2004.02.010","article-title":"Therapeutic effect of cevimeline on dry eye in patients with Sjogrens syndrome: a randomized, double-blind clinical study.","volume":"138","author":"Ono","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R45-16-20210204","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/bjo.2003.026211","article-title":"Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease.","volume":"88","author":"Noble","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"R46-16-20210204","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/sj.bmt.1703862","article-title":"Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.","volume":"31","author":"Ogawa","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"R47-16-20210204","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ajo.2004.08.040","article-title":"The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study.","volume":"139","author":"Kojima","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R48-16-20210204","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/sj.bmt.1705426","article-title":"Risk factors and characteristics of ocular complications, and efficacy of autologous serum tears after haematopoietic progenitor cell transplantation.","volume":"38","author":"Leite","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"R49-16-20210204","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/sj.bmt.1702334","article-title":"GVHD dry eyes treated with autologous serum tears.","volume":"25","author":"Rocha","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"R50-16-20210204","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/bjo.83.4.390","article-title":"Treatment of dry eye by autologous serum application in Sjogrens syndrome.","volume":"83","author":"Tsubota","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"R51-16-20210204","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ophtha.2003.10.019","article-title":"Autologous serum application in the treatment of neurotrophic keratopathy.","volume":"111","author":"Matsumoto","year":"2004","journal-title":"Ophthalmology"},{"key":"R52-16-20210204","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s00347-008-1692-4","article-title":"Manufacture of autologous serum eye drops for out-patient therapy: cooperation between ophthalmic clinic and transfusion medicine department [in German].","volume":"105","author":"Dietrich","year":"2008","journal-title":"Ophthalmologe"},{"key":"R53-16-20210204","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.bmt.1705566","article-title":"Therapeutic effect of umbilical cord serum eyedrops for the treatment of dry eye associated with graft-versus-host disease.","volume":"39","author":"Yoon","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"R54-16-20210204","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/ICO.0b013e3180645cd7","article-title":"Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.","volume":"26","author":"Chiang","year":"2007","journal-title":"Cornea"},{"key":"R55-16-20210204","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1136\/bjo.2007.117572","article-title":"HIV and hepatitis B\/C infections in patients donating blood for use as autologous serum eye drops.","volume":"91","author":"Weisbach","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R56-16-20210204","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.ICL.0000060998.20142.8D","article-title":"Increase in tear film lipid layer thickness following treatment with warm compresses in patients with meibomian gland dysfunction.","volume":"29","author":"Olson","year":"2003","journal-title":"Eye Contact Lens"},{"key":"R57-16-20210204","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/01.icl.0000244154.76214.2d","article-title":"Extended-wear silicone hydrogel soft contact lenses in the management of moderate to severe dry eye signs and symptoms secondary to graft-versus-host disease.","volume":"33","author":"Russo","year":"2007","journal-title":"Eye Contact Lens"},{"key":"R58-16-20210204","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1076\/orbi.22.3.203.15614","article-title":"Surgical treatment of dry eye.","volume":"22","author":"Murube","year":"2003","journal-title":"Orbit"},{"key":"R59-16-20210204","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/00003226-200111000-00002","article-title":"Tarsorrhaphy: clinical experience from a cornea practice.","volume":"20","author":"Cosar","year":"2001","journal-title":"Cornea"},{"key":"R60-16-20210204","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0039-6257(96)82013-3","article-title":"Treatment of dry eye by blocking the lacrimal canaliculi.","volume":"40","author":"Murube","year":"1996","journal-title":"Surv Ophthalmol"},{"key":"R61-16-20210204","first-page":"1521","article-title":"Three-year revision. American Academy of Ophthalmology.","volume":"104","year":"1997","journal-title":"Ophthalmology"},{"key":"R62-16-20210204","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0002-9394(00)00620-6","article-title":"Efficacy and tolerability outcomes after punctal occlusion with silicone plugs in dry eye syndrome.","volume":"131","author":"Balaram","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"R63-16-20210204","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000131090","article-title":"Plugs for occlusion of the lacrimal drainage system.","volume":"41","author":"Tost","year":"2008","journal-title":"Dev Ophthalmol"},{"key":"R64-16-20210204","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000131091","article-title":"Surgical occlusion of the lacrimal drainage system.","volume":"41","author":"Geerling","year":"2008","journal-title":"Dev Ophthalmol"},{"key":"R65-16-20210204","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/ICO.0b013e318155743d","article-title":"Boston scleral lens prosthetic device for treatment of severe dry eye in chronic graft-versus-host disease.","volume":"26","author":"Jacobs","year":"2007","journal-title":"Cornea"},{"key":"R66-16-20210204","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/ICU.0b013e328302cc4f","article-title":"Update on scleral lenses.","volume":"19","author":"Jacobs","year":"2008","journal-title":"Curr Opin Ophthalmol"},{"key":"R67-16-20210204","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ajo.2009.07.037","article-title":"Clinical benefits of the Boston Ocular Surface Prosthesis.","volume":"149","author":"Stason","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"R68-16-20210204","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.bbmt.2007.05.006","article-title":"Use of fluid-ventilated, gas-permeable scleral lens for management of severe keratoconjunctivitis sicca secondary to chronic graft-versus-host disease.","volume":"13","author":"Takahide","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"R69-16-20210204","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s003470050519","article-title":"Ocular involvement in graft versus host disease after bone marrow transplantation [in German].","volume":"97","author":"Mittelviefhaus","year":"2000","journal-title":"Ophthalmologe"},{"key":"R70-16-20210204","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1600-0420.2006.00658.x","article-title":"Ocular complications in a child with acute graft-versus-host disease following cord blood stem cell transplantation: therapeutic challenges.","volume":"84","author":"Uchino","year":"2006","journal-title":"Acta Ophthalmol Scand"},{"key":"R71-16-20210204","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/112067210101100215","article-title":"Multilayer amniotic membrane transplantation in severe ocular graft versus host disease.","volume":"11","author":"Peris-Martinez","year":"2001","journal-title":"Eur J Ophthalmol"},{"key":"R72-16-20210204","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.survophthal.2003.10.004","article-title":"The amniotic membrane in ophthalmology.","volume":"49","author":"Dua","year":"2004","journal-title":"Surv Ophthalmol"},{"key":"R73-16-20210204","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/bjo.2006.108134","article-title":"Amniotic membrane-covered bio-onlays for treatment of ocular surface disease.","volume":"91","author":"Cursiefen","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R74-16-20210204","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/ICO.0b013e31818526a6","article-title":"Ocular surface reconstruction in graft-versus-host disease with HLA-identical living-related allogeneic cultivated limbal epithelium after hematopoietic stem cell transplantation from the same donor.","volume":"28","author":"Meller","year":"2009","journal-title":"Cornea"},{"key":"R75-16-20210204","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/bjo.77.8.525","article-title":"Penetrating keratoplasty in severe ocular graft versus host disease.","volume":"77","author":"Heath","year":"1993","journal-title":"Br J Ophthalmol"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003226-201203000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:29:27Z","timestamp":1786048167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003226-201203000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e318226bf97","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}